MYCBP2-AS1
gene geneOn this page
Summary
MYCBP2-AS1 (MYCBP2 antisense RNA 1, HGNC:41023) is a long non-coding RNA gene on chromosome 13q22.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41023 |
| Approved symbol | MYCBP2-AS1 |
| Name | MYCBP2 antisense RNA 1 |
| Location | 13q22.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000236051 |
| Ensembl biotype | lncRNA |
| Entrez | 100874212 |
| RNAcentral | URS000075B177 — lncRNA, 517 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 10 lncRNA
ENST00000422231, ENST00000448470, ENST00000450627, ENST00000593933, ENST00000596342, ENST00000627409, ENST00000629771, ENST00000630676, ENST00000631152, ENST00000636737
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000422231 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001593784 | 77083010 | 77083112 |
| ENSE00001667618 | 77075514 | 77075584 |
| ENSE00001683709 | 77087552 | 77087778 |
| ENSE00001800358 | 77076816 | 77076933 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 91.82.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1751 / max 25.0367, expressed in 71 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 135500 | 0.1751 | 71 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.82 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.47 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.96 | gold quality |
| bone marrow cell | CL:0002092 | 79.33 | gold quality |
| colonic epithelium | UBERON:0000397 | 79.19 | gold quality |
| corpus callosum | UBERON:0002336 | 78.05 | gold quality |
| bone marrow | UBERON:0002371 | 75.46 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.63 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 71.26 | gold quality |
| cortical plate | UBERON:0005343 | 69.60 | gold quality |
| muscle tissue | UBERON:0002385 | 69.54 | gold quality |
| ventricular zone | UBERON:0003053 | 69.52 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 68.28 | gold quality |
| skin of leg | UBERON:0001511 | 67.79 | gold quality |
| tibial artery | UBERON:0007610 | 67.78 | gold quality |
| ganglionic eminence | UBERON:0004023 | 67.76 | gold quality |
| skin of abdomen | UBERON:0001416 | 67.74 | gold quality |
| popliteal artery | UBERON:0002250 | 67.72 | gold quality |
| zone of skin | UBERON:0000014 | 67.71 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 67.70 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.72 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 66.71 | gold quality |
| monocyte | CL:0000576 | 66.49 | gold quality |
| tonsil | UBERON:0002372 | 66.34 | gold quality |
| blood | UBERON:0000178 | 65.49 | gold quality |
| ectocervix | UBERON:0012249 | 64.89 | gold quality |
| muscle of leg | UBERON:0001383 | 64.80 | gold quality |
| adipose tissue | UBERON:0001013 | 64.76 | gold quality |
| uterine cervix | UBERON:0000002 | 64.53 | gold quality |
| tibial nerve | UBERON:0001323 | 64.25 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.97 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.